Prodia Diagnostic Line Tbk vs Saraswanti Indoland Development Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp266 (market cap 470.58B, 14.52M 24h volume), while Saraswanti Indoland Development Tbk. trades at Rp108 (market cap 608.51B, 10.95M 24h volume). The key difference: Saraswanti Indoland Development Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (14.52M versus 10.95M). Which is the better fit depends on your goals.
| PRDL | SWID | |
|---|---|---|
Market Cap | 470.58B | 608.51B |
Volume | 14.52M | 10.95M |
Lot | 145.17K | 109.48K |
Turnover | 3.82B | 1.21B |
Average Price | 263.17 | 110.23 |
Value | 3.82B | 1.21B |
Indicative Equilibrium Price | 272 | 114 |
Indicative Equilibrium Volume | 418 | 1.97K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →